isamogu

Isamogu Inc. is a South Korean direct-to-consumer (D2C) healthcare and beauty company founded in 2019. The company specializes in "skin science" and "inner care" through its flagship brands, Celladix and LACTOMEDI. Celladix focuses on derma-cosmetics that address fundamental skin issues like acne and barrier repair, while LACTOMEDI provides feminine hygiene and health solutions, including probiotic-based gels and washes. Isamogu utilizes clinical trials to validate its formulations and operates its own online stores to maintain a direct relationship with its global customer base. The company has expanded its presence internationally, including a dedicated branch in Japan and distribution in the United States.